Description of the 3 Tranquillo Phase 3 clinical program study designs to assess ritlecitinib treatment in adults and adolescents with nonsegmental vitiligo. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s714, 2025. DOI: 10.25251/rm8etw25. Disponível em: https://skin.dermsquared.com/skin/article/view/3860. Acesso em: 25 may. 2026.